Determination of etoposide serum concentrations in small pediatric samples by an improved method of reversed-phase high-performance liquid chromatography.
Several specific assays have been developed for the measurement of etoposide in biological fluids. As large samples are required for high sensitivity, these systems are not appropriate for a pediatric practice. In the present study, however, an improved method for the determination of serum levels of the anticancer drug etoposide was developed, using high-performance liquid chromatography with fixed-wavelength ultraviolet detection. Etoposide was extracted from serum using dichloromethane. The efficiency of extraction from serum was 85.7 +/- 7.7% for etoposide and 81.1 +/- 8.4% for diphenylhydantoin, the internal standard. The serum concentrations of etoposide were measured in 0.2-ml serum samples. The lower limit of detection was 50 ng/ml. Each measurement was completed within 5 min. The linear quantitation range for etoposide was 0.05-50 microg/ml. This assay presents an alternative method for routine measurement of serum levels of etoposide in the pediatric oncology setting.
Kato
Yasuhiro
Y
Department of Pediatrics, National Hiroshima Hospital Higashi-Hiroshima 739-0041, Japan. Yasuhiro.Kato@mb7.seikyou.ne.jp
Mawatari
Hideo
H
Nishimura
Shin-Ichiro
S
Sakura
Nobuo
N
Ueda
Kazuhiro
K
D000972:Antineoplastic Agents, Phytogenic / Q000097:blood*; D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005047:Etoposide / Q000097:blood*; D006801:Humans; D012680:Sensitivity and Specificity
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide